european end-to-end CDMO company, pharma services
  • About us
    • History
    • Leaderships
    • Team
    • EU grants
    • Requests for Proposal
    • Sustainability – ESG
    • Bussines strategy
    • Quality policy
    • Virtual Tour
  • Services
    • Drug Substance Manufacturing
    • Fill & Finish
    • Gene to Vial: End-to-End Development
    • Process Development
    • Analytics 
    • Cell Line Development & Banking
  • Science Hub
    • Science News
    • Resources
  • News & Events
    • Press releases
    • Events
    • Content to download
  • Investors
    • Corporate documents
    • Shareholders and shares
    • Periodic reports
    • Current reports
    • Sustainability reports
    • Corporate governance at Mabion
    • Financial data
    • For Investors
    • Calendar
  • Contact us
    • Contact form
    • Contact for investors
    • Contact for media
    • Careers
  • EN
    • PL
  • Science News
  • Resources

Resources

Topic
All Analytics Antibody-drug conjugates Bioanalytics Biologics Biosimilars Biostatistics Cancer Cell culture Clinical trials Contamination Drug development Drug product Drug substance EMA FDA GMP Mabion Manufacturing Microbiology Partnership Proteins Regulatory Vaccines Veterinary biologics
Type
All Poster
Meeting global regulatory standards in biologic drug manufacturing projects in Mabion Biologics

Meeting Global Regulatory Standards in Biologic Drug Manufacturing Projects

Biologics, EMA, FDA, GMP, Mabion, Manufacturing, Regulatory
cell line development

Tailoring Cell Line Development for Efficient Biologics Process Outcomes

Biologics, Drug development, GMP, Manufacturing
ADC development

Challenges and Solutions in ADC Development for Biologic Therapeutics

Antibody-drug conjugates, Biologics, Drug development
gmp biologics manufacturing

GMP Biologics Manufacturing in End-to-End Drug Development

Biologics, Drug development, GMP, Manufacturing
Biggest Analytical Challenges in Biosimilar Characterization and Comparability

5 Analytical Challenges in Biosimilar Characterization and Comparability

Biologics, Drug development
recombinant protein production

Strategies for High-Quality Recombinant Protein Production

Manufacturing, Proteins
1 2 … 12 Next

Contact

Find out how we may support your business.

bd@mabion.eu

Mabion

gen. Mariana Langiewicza 60
95-050 Konstantynów Łódzki
Poland

+48 42 207 78 90

    Mabion
    • Privacy policy
    • Services
    • Investors
    • News&Events
    • Contact us

    This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. Page Sitemap.

    Powered by

    Veneo